STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research
STXBP1 syndrome is a severe early-onset epileptic encephalopathy characterized by developmental delay and intellectual disability. This review addresses key challenges in STXBP1 syndrome research, focusing on advanced therapeutic approaches and experimental models. We explore gene therapy strategies...
| Autores: | , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Recursos: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/394847 |
| Acesso em linha: | http://hdl.handle.net/10261/394847 https://api.elsevier.com/content/abstract/scopus_id/105001154135 |
| Access Level: | acceso abierto |
| Palavra-chave: | STXBP1 Antisense oligonucleotides Bioinformatics Epilepsy Gene and cell therapy Genomics Haploinsufficiency Induced pluripotent stem cells Infantile epileptic encephalopathy Murine models Personalized medicine |
| id |
ES_5657119fefefcb3168b06348a97c0d16 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/394847 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational ResearchRuano-Rodríguez, SilvestreNavarro-Alonso, MarDomínguez-Velasco, BenitoÁlvarez-Dolado, ManuelEsteban, Francisco J.STXBP1Antisense oligonucleotidesBioinformaticsEpilepsyGene and cell therapyGenomicsHaploinsufficiencyInduced pluripotent stem cellsInfantile epileptic encephalopathyMurine modelsPersonalized medicineSTXBP1 syndrome is a severe early-onset epileptic encephalopathy characterized by developmental delay and intellectual disability. This review addresses key challenges in STXBP1 syndrome research, focusing on advanced therapeutic approaches and experimental models. We explore gene therapy strategies, including CRISPR-Cas9, adeno-associated viral (AAV) vectors, and RNA therapies such as antisense oligonucleotides (ASOs), aimed at correcting STXBP1 genetic dysfunctions. This review presents in vivo and in vitro models, highlighting their contributions to understanding disease mechanisms. Additionally, we provide a proposal for a detailed bioinformatic analysis of a Spanish cohort of 41 individuals with STXBP1-related disorders, offering insights into specific mutations and their biological implications. Clinical and translational perspectives are discussed, emphasizing the potential of personalized medicine approaches. Future research directions and key challenges are outlined, including the identification of STXBP1 interactors, unexplored molecular pathways, and the need for clinically useful biomarkers. This comprehensive review underscores the complexity of STXBP1-related infantile epileptic encephalopathy and opens new avenues for advancing the understanding and treatment of this heterogeneous disease.This work was supported by the Asociación Síndrome STXBP1 (España), the Ministerio de Ciencia Innovación y Universidades/Agencia Estatal de Investigación/European Regional Development Fund, UE Grants (RTI2018-099768-B-100; PID2021-127044OB-I00 to A.M. and PID2021-122991NB-C21 to E.F.J.), and Universidad de Jaén (PAIUJA-EI_CTS02_2023)—Junta de Andalucía (BIO-302) to E.F.J.Peer reviewedMultidisciplinary Digital Publishing InstituteAsociación Síndrome STXBP1 (España)Agencia Estatal de Investigación (España)Ministerio de Ciencia, Innovación y Universidades (España)Ministerio de Ciencia e Innovación (España)Junta de AndalucíaUniversidad de JaénÁlvarez-Dolado, Manuel [0000-0002-0655-8289]Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202520252025info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/394847https://api.elsevier.com/content/abstract/scopus_id/105001154135reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-099768-B-I00info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-127044OB-I00info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-122991NB-C21https://doi.org/10.3390/biotech14010011Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3948472026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research |
| title |
STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research |
| spellingShingle |
STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research Ruano-Rodríguez, Silvestre STXBP1 Antisense oligonucleotides Bioinformatics Epilepsy Gene and cell therapy Genomics Haploinsufficiency Induced pluripotent stem cells Infantile epileptic encephalopathy Murine models Personalized medicine |
| title_short |
STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research |
| title_full |
STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research |
| title_fullStr |
STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research |
| title_full_unstemmed |
STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research |
| title_sort |
STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research |
| dc.creator.none.fl_str_mv |
Ruano-Rodríguez, Silvestre Navarro-Alonso, Mar Domínguez-Velasco, Benito Álvarez-Dolado, Manuel Esteban, Francisco J. |
| author |
Ruano-Rodríguez, Silvestre |
| author_facet |
Ruano-Rodríguez, Silvestre Navarro-Alonso, Mar Domínguez-Velasco, Benito Álvarez-Dolado, Manuel Esteban, Francisco J. |
| author_role |
author |
| author2 |
Navarro-Alonso, Mar Domínguez-Velasco, Benito Álvarez-Dolado, Manuel Esteban, Francisco J. |
| author2_role |
author author author author |
| dc.contributor.none.fl_str_mv |
Asociación Síndrome STXBP1 (España) Agencia Estatal de Investigación (España) Ministerio de Ciencia, Innovación y Universidades (España) Ministerio de Ciencia e Innovación (España) Junta de Andalucía Universidad de Jaén Álvarez-Dolado, Manuel [0000-0002-0655-8289] Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
STXBP1 Antisense oligonucleotides Bioinformatics Epilepsy Gene and cell therapy Genomics Haploinsufficiency Induced pluripotent stem cells Infantile epileptic encephalopathy Murine models Personalized medicine |
| topic |
STXBP1 Antisense oligonucleotides Bioinformatics Epilepsy Gene and cell therapy Genomics Haploinsufficiency Induced pluripotent stem cells Infantile epileptic encephalopathy Murine models Personalized medicine |
| description |
STXBP1 syndrome is a severe early-onset epileptic encephalopathy characterized by developmental delay and intellectual disability. This review addresses key challenges in STXBP1 syndrome research, focusing on advanced therapeutic approaches and experimental models. We explore gene therapy strategies, including CRISPR-Cas9, adeno-associated viral (AAV) vectors, and RNA therapies such as antisense oligonucleotides (ASOs), aimed at correcting STXBP1 genetic dysfunctions. This review presents in vivo and in vitro models, highlighting their contributions to understanding disease mechanisms. Additionally, we provide a proposal for a detailed bioinformatic analysis of a Spanish cohort of 41 individuals with STXBP1-related disorders, offering insights into specific mutations and their biological implications. Clinical and translational perspectives are discussed, emphasizing the potential of personalized medicine approaches. Future research directions and key challenges are outlined, including the identification of STXBP1 interactors, unexplored molecular pathways, and the need for clinically useful biomarkers. This comprehensive review underscores the complexity of STXBP1-related infantile epileptic encephalopathy and opens new avenues for advancing the understanding and treatment of this heterogeneous disease. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 2025 2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/394847 https://api.elsevier.com/content/abstract/scopus_id/105001154135 |
| url |
http://hdl.handle.net/10261/394847 https://api.elsevier.com/content/abstract/scopus_id/105001154135 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
#PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-099768-B-I00 info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-127044OB-I00 info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-122991NB-C21 https://doi.org/10.3390/biotech14010011 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
| publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869408372927758336 |
| score |
15,811543 |